Lycia Therapeutics files for IPO on Nasdaq under symbol LYCA
Lycia Therapeutics has filed for an initial public offering of its common stock on the Nasdaq, aiming to trade under the symbol 'LYCA'. Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities, and Lifesci Capital are listed as underwriters.